You are here

patents

Lilly wards off another Alimta patent challenge, this time through IPR

Fierce Pharma

Fri, 10/6/17 - 11:42 am

Allergan shows how you can destroy your rep and get mobbed by lawmakers in 4 easy steps

Endpoints

Fri, 10/6/17 - 09:44 am

U.S. court reverses ban on sale of Sanofi, Regeneron drug Praluent

Yahoo/Reuters

Thu, 10/5/17 - 11:46 am

3 Big Pharma Stocks Set to Succeed

Motley Fool

Thu, 10/5/17 - 09:36 am

Sanofi and Regeneron, seeking to shield Dupixent, lose first IPR try against Amgen

Fierce Pharma

Thu, 10/5/17 - 09:34 am

Allergan defends Restasis deal by calling for review of patent challenge process

Fierce Pharma

Tue, 10/3/17 - 11:59 am

Allergan’s tribal treaty in Restasis patent fight triggers a Congressional dispute

Endpoints

Thu, 09/28/17 - 09:37 am

Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It

Bloomberg

Wed, 09/20/17 - 09:14 am

5 Ways to Predict Patent Litigation Outcomes

Drug Patent Watch

Mon, 09/18/17 - 10:13 am

patent lawsuits

Mylan attacks Allergan over its Mohawk-allied patent strategy — but the CEO is sticking to his guns

Endpoints

Wed, 09/13/17 - 10:35 am

Pharma’s five favorite tricks to protect a monopoly

Stat

Mon, 09/11/17 - 09:13 pm

Allergan's Patent Loophole Could Be a Huge Gift for Pfizer

Motley Fool

Mon, 09/11/17 - 09:54 am

Allergan CEO gambles a multibillion-dollar franchise — and his company rep — on a high-stakes bet at an Indian casino op

Endpoints

Sat, 09/9/17 - 01:21 pm

This Shield of Patents Protects the World’s Best-Selling Drug

Bloomberg

Fri, 09/8/17 - 09:25 am

Using Patent Filings to Model Branded Pharmaceutical Post-Expiration Strategies

Drug Patent Watch

Thu, 09/7/17 - 05:38 pm

Mallinckrodt tumbles after judge invalidates Inomax patents

BioPharma Dive

Wed, 09/6/17 - 08:34 pm

Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve

NY Shock Exchange

Wed, 09/6/17 - 09:11 am

Teva Pharmaceutical

PhRMA, BIO push back against Nevada patent law

BioPharma Dive

Tue, 09/5/17 - 09:37 am

Pfizer Wins Indian Patent on Prevnar 13 Vaccine

RAPS.org

Tue, 08/22/17 - 06:43 pm

The decade's top 10 patent losses, worth a whopping $915B in lifetime sales

Fierce Pharma

Thu, 08/17/17 - 10:36 am

Pages